Consensus statement on iron overload in myelodysplastic syndromes

被引:143
|
作者
Bennett, John M. [1 ]
机构
[1] Myelodysplast Syndromes Fdn, Crosswicks, NJ USA
关键词
D O I
10.1002/ajh.21269
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In May 2005 at the 8th International Symposium on Myelodysplastic Syndromes (MDS), a consensus meeting was held on iron overload in MDS (Seymour, Hematol Oncol Clin 2005; Suppl 1:18-25). The recommendations of the 2005 consensus meeting were discussed in the context of currently available evidence at the 9th International Symposium on Myelodysplastic Syndromes in Florence Italy, May 2007. The recommendations of the consensus working group are presented here. The recommendations are a continued refinement of the outcome of the 2005 consensus meeting and the ground-breaking work of others in this area (Seymour, Hematol Oncol Clin 2005; Suppl 1:18-25; Gattermann, Int J Hematol 2008;88:24-29; Alessandrino et al., Haematologica 2002;87:1286-1306; NCCN practice guidelines: Myelodysplastic Syndromes, version 2.2008). Am. J. Hematol. 83:858-861, 2008. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:858 / 861
页数:4
相关论文
共 50 条
  • [41] Iron overload in myelodysplastic
    Rachmilewitz, E. A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (06) : 553 - 553
  • [42] Iron chelation therapy in patients with myelodysplastic syndromes: Consensus conference guidelines
    Mittelman, Moshe
    Lugassy, Gilles
    Merkel, Drorit
    Tamary, Hannah
    Sarid, Nadav
    Rachmilewitz, Eliezer
    Hershko, Chaim
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (05): : 374 - 376
  • [43] A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes
    Cermak, Jaroslav
    Jonasova, Anna
    Vondrakova, Jana
    Cervinek, Libor
    Belohlavkova, Petra
    Neuwirtova, Radana
    LEUKEMIA RESEARCH, 2013, 37 (12) : 1612 - 1615
  • [44] Ironing out the details of iron overload in myelofibrosis: Lessons from myelodysplastic syndromes
    Carreau, Nicole
    Tremblay, Douglas
    Savona, Michael
    Kremyanskaya, Marina
    Mascarenhas, John
    BLOOD REVIEWS, 2016, 30 (05) : 349 - 356
  • [45] MORTALITY BURDEN OF TRANSFUSION DEPENDENCY AND IRON OVERLOAD IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES.
    Arnan, M.
    Pomares, H.
    Esteban, L.
    Alonso, E.
    Pareja, L.
    Sanchez-Ortega, I.
    Fernandez de Sevilla, A.
    Ribes, J.
    Duarte, R.
    HAEMATOLOGICA, 2013, 98 : 86 - 86
  • [46] Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes
    Jabbour, Elias
    Kantarjian, Hagop M.
    Koller, Charles
    Taher, Ali
    CANCER, 2008, 112 (05) : 1089 - 1095
  • [47] Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes
    Malcovati, Luca
    LEUKEMIA RESEARCH, 2007, 31 : S2 - S6
  • [48] Pathogenesis of iron overload in myelodysplastic syndromes and the debate on iron chelation in low-risk MDS
    Shenoy, Niraj
    Verma, Amit
    Ginzburg, Yelena
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S85 - S85
  • [49] The Relevance of Iron Overload and the Appropriateness of Iron Chelation Therapy for Patients with Myelodysplastic Syndromes: A Dialogue and Debate
    David P. Steensma
    Current Hematologic Malignancy Reports, 2011, 6 : 136 - 144
  • [50] Labile Plasma Iron (LPI), More Practical and More Sensitive to Iron Overload in Myelodysplastic Syndromes
    Chang, Chunkang
    Gu, Shucheng
    Guo, Juan
    Zhao, Youshan
    Fei, Chengming
    Li, Xiao
    BLOOD, 2015, 126 (23)